-
With over 20 years of experience in human nutrition. We help you deliver better nutrition in your foods, beverages, or supplements.
Check out our animal nutrition ingredients, designed to boost the health and vitality of all your favorite livestock. -
We provide tailored health solutions across various fields with independent R&D technology.
We offer professional teams to deliver customized solutions based on your product requirements. -
Address common doubts and curiosities, offering clear and informative solutions. We demystify common queries and provide valuable insights in every issue!
You can access comprehensive information to stay informed and ahead in your field. Explore and download our extensive library today! -
Recently, INNOBIO's LocVita® Pine-Based Vitamin D3 has officially passed the certification of the FSSAI and is permitted to enter the Indian market as a vegetarian functional nutritional ingredient.
INNOBIO Europe B.V, the European branch of INNOBIO Co., Ltd. was launched in Rotterdam, Netherlands. -
INNOBIO’s microencapsulation technology has evolved into its third generation (IMT 3.0) through iterative research of active ingredients, microencapsulating materials, equipment, and more.
With our patented biosynthesis technology platform, INNOBIO strives to provide an alternative to chemical synthesis to provide more natural and healthy ingredients to the nutrition industry.
The True Liposomal Silybin: Why not unlock high bioavailability with Durlip™?
INNOBIO is raising the bar in nutritional ingredient technology with the launch of Durlip™ Liposomal Silybin. By addressing the long-standing formulation challenges associated with traditional milk thistle extracts, Durlip™ offers a highly bioavailable and water-dispersible solution that opens new possibilities for supplement manufacturers.
Silybin, the primary active flavonoid in silymarin, is well known for its strong antioxidant properties and its role in supporting liver health and the body's natural detoxification processes[1]. However, its use in commercial applications has traditionally been limited by poor water solubility, resulting in low bioavailability and formulation difficulties.
Durlip™ Liposomal Silybin overcomes these challenges through three key innovations:
· Superior Water Dispersibility
Traditional silybin ingredients are inherently hydrophobic and difficult to formulate. Durlip™ offers excellent water dispersibility, allowing it to integrate seamlessly into a wide range of liquid and semi-solid formats. This makes it suitable for applications, including clear beverages, functional foods, and liquid supplements, where traditional silybin have failed.
· Verified Liposomal Integrity
True liposomal delivery goes beyond simple mixing. INNOBIO applies a rigorous liposomal validation system to ensure consistent product performance. X-Ray Diffraction (XRD) analysis reveals a distinct crystalline transformation in Durlip™, providing direct evidence of successful encapsulation. Furthermore, unlike simple physical blends that remain insoluble, Durlip™ dissolves completely in dichloromethane, confirming the formation of a true liposomal complex rather than a mixture.
· Clinically Relevant Bioavailability
The goal of liposomal technology is to enhance ingredient delivery. Through advanced encapsulation techniques, Durlip™ protects silybin during digestion and supports targeted release at the intestinal wall. Pharmacokinetic studies show that Durlip™ achieves a faster peak plasma concentration and significantly greater overall bioavailability compared to standard silybin extracts. This ensures the ingredient is effectively absorbed and the utilized by the body for maximum benefit.
"Durlip™ represents a major advancement for formulators looking to leverage the benefits of Liposomal Silybin," said a representative from INNOBIO. "By validating the liposomal structure and proving our enhanced absorption profile, we offer a solution that is both science-backed and application-friendly."
Reference: [1] Di Costanzo, Alfonso, and Ruggero Angelico. "Formulation strategies for enhancing the bioavailability of silymarin: the state of the art." Molecules 24.11 (2019): 2155.
Get product quotes for free, find the right solution with our experts.
Know more about our organization and teams, join us or meet at an exhibition.
Keep connecting with us. Say it and be sorted.
All Rights Reserved © 2024 INNOBIO Corporation Limited